Nucleic Acid Labeling Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented By Label Type (Biotin-based, Fluorescent, Radioactive, and Other Label Types), Application, End-User, and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.

Scope of the Report

As per the scope of the report, nucleic acids are complex biomolecules that are responsible for the transfer of genetic information in all living organisms. Nucleic acid labeling is a procedure in which nucleic acids are modified or attached with tags that enable their detection or purification.

By Label Type
Other Label Types
By Application
DNA Sequencing
In situ Hybridization
Polymerase Chain Reaction
Other Applications
By End User
Diagnostic Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Biotin Based Segment is Expected to Show Better Growth Over the Forecast Period

Based on label type, the market is segmented into biotin-based, fluorescent, radioactive and other label types. Non-radioactively labeled probes, such as biotin-based probes have several advantages over radioactive probes, such as increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. Furthermore, there have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique’s limitations. Pertaining to these advancements, the biotin-based label segment is expected to show better growth during the forecast period.

Nucleic Acid Labeling Market 1

North America is Expected to Dominate the Nucleic Acid Labeling Market

The nucleic acid labeling market dominates the North America region due to the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, and favorable government initiatives. In recent years, several government initiatives have been launched, which is supplementing the growth of the nucleic acid labeling market in the United States. For instance, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, which has accelerated the growth of the nucleic acid labeling and its acceptance as well as adoption in the region.

Nucleic Acid Labeling Market 2

Competitive Landscape

The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Genomic and Enzymology Research

      2. 4.2.2 Advancements in Tools for Synthetic Genome Design

      3. 4.2.3 Growing Demand for Personalized Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Professionals

      2. 4.3.2 High Cost and Complexity of Techniques

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Label Type

      1. 5.1.1 Biotin-based

      2. 5.1.2 Fluorescent

      3. 5.1.3 Radioactive

      4. 5.1.4 Other Label Types

    2. 5.2 By Application

      1. 5.2.1 Microarray

      2. 5.2.2 DNA Sequencing

      3. 5.2.3 In situ Hybridization

      4. 5.2.4 Polymerase Chain Reaction

      5. 5.2.5 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals/Clinics

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Enzo Biochem Inc.

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Marker Gene Technologies Inc.

      4. 6.1.4 Merck KGaA

      5. 6.1.5 New England Biolabs Inc.

      6. 6.1.6 PerkinElmer Inc.

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Vector Laboratories Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Nucleic Acid Labeling Market market is studied from 2018 - 2026.

The Nucleic Acid Labeling Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific are the major companies operating in Nucleic Acid Labeling Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!